The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksApax Global Alpha Regulatory News (APAX)

Share Price Information for Apax Global Alpha (APAX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 142.00
Bid: 141.20
Ask: 142.80
Change: 1.00 (0.71%)
Spread: 1.60 (1.133%)
Open: 142.60
High: 145.00
Low: 142.00
Prev. Close: 141.00
APAX Live PriceLast checked at -
Apax Global Alpha is an Investment Trust

To provide shareholders with capital appreciation from our investment portfolio and regular dividends.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

10 Sep 2020 11:39

RNS Number : 6218Y
Apax Global Alpha Limited
10 September 2020
 

 

(LSE: APAX)

Apax Global Alpha Limited

 

PDMR Dealing

 

This notification is made in accordance with DTR 3.1 of the Disclosure and Transparency Rules and article 19(1) of the Market Abuse Regulations (EU) no. 596/2014 ("MAR").

 

The Company was notified on 09 September 2020 that, Mr Andrew Guille who is a director of Apax Guernsey Managers Limited, has beneficially acquired 10,000 Ordinary Shares. The 10,000 shares were purchased on 09 September 2020 at an average price of £1.6442 per share. These shares will be held through a nominee arrangement. Following the purchase, Mr Andrew Guille owns 48,868 Ordinary Shares, representing less than 1% of the Company's total issued share capital.

 

 

Contact details

 

Investor relations

Lorraine Rees

IR Manager - AGA

Telephone: +44 (0)207 872 6381

Email: Lorraine.Rees@apax.com

Company secretary

Lewis Germain/ Christopher Copperwaite

Company Secretary

Telephone: +44 (0) 1481 749 700

Email: AGA-admin@aztecgroup.co.uk

 

Notes

 

1.

Note that references in this announcement to Apax Global Alpha Limited have been abbreviated to "AGA" or "the Company". References to Apax Partners LLP have been abbreviated to "Apax Partners" or "the Investment Adviser"

2.

This announcement is not for release, publication or distribution, directly or indirectly, in whole or in part, into or within the United States or to "US persons" (as defined in Regulation S under the United States Securities Act of 1933, as amended (the "Securities Act")) or into or within Australia, Canada, South Africa or Japan. Recipients of this announcement in jurisdictions outside the UK should inform themselves about and observe any applicable legal requirements in their jurisdictions. In particular, the distribution of the announcement may be restricted by law in certain jurisdictions.

 

 

 

About Apax Global Alpha Limited

 

AGA is a Guernsey registered closed-ended collective investment scheme incorporated as a non-cellular company that listed on the London Stock Exchange on 15 June 2015. It is regulated by the Guernsey Financial Services Commission.

AGA's objective is to provide shareholders with capital appreciation from its investment portfolio and regular dividends. The Company is targeting an annualised Total Return, across economic cycles, of 12-15% (net of fees and expenses) including a dividend yield of 5% of Net Asset Value.

 

The investment policy of the Company is to make Private Equity investments in Apax Funds, and Derived Investments which are investments in equities and debt derived from the insights gained via Apax Partners' Private Equity activities. Further information regarding the Company and its publications are available on the Company's website at www.apaxglobalalpha.com.

 

About Apax Partners LLP

 

Apax Partners LLP ("Apax Partners") is a leading global private equity advisory firm and over its more than 40-year history, Apax Partners has raised and advised funds with aggregate commitments of over €40 billion. Funds advised by Apax Partners invest in companies across four global sectors of Tech & Telco, Services, Healthcare and Consumer. These funds provide longterm equity financing to build and strengthen worldclass companies. For further information about Apax Partners, please visit www.apax.com. Apax Partners is authorised and regulated by the Financial Conduct Authority in the UK.

 

 

 

 

1

 

Details of the person discharging managerial responsibilities / person closely associated

 

a)

 

Name

 

 

ANDREW GUILLE

2

 

Reason for the notification

 

a)

 

Position/status

 

 

PDMR - INVESTMENT MANAGER

b)

 

Initial notification /Amendment

 

 

INITIAL

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

 

a)

 

Name

 

APAX GLOBAL ALPHA LIMITED

b)

 

LEI

 

21380031LQE8CU8NU843

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

 

 

a)

 

Description of the financial instrument, type of instrument

 

Identification code

 

ORDINARY SHARES

 

 

APAX

b)

 

Nature of the transaction

 

 

PURCHASE

c)

 

Price(s) and volume(s)

 

 

Price(s)

 

Volume(s)

£1.6442

10,000

 

 

d)

 

Aggregated information

 

 

- Aggregated volume

 

 

- Price

 

AS IN 4 C) ABOVE

 

 

 

 

 

 

e)

 

Date of the transaction

 

09 September 2020

f)

 

Place of the transaction

 

 

LONDON STOCK EXCHANGE

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGGDCIXBDGGG
Date   Source Headline
13th Jan 202311:10 amEQSHardman & Co Research on Apax Global Alpha (Initiation of coverage): Making pearls out of oysters
13th Jan 20237:00 amRNSDuck Creek Technologies to be acquired by Vista
10th Nov 20227:00 amRNSApax IX sells stake in Kepro
4th Nov 20227:00 amRNSQuarterly Results for 30 September 2022
22nd Sep 20227:00 amRNSApax IX agrees to sell stake in Authority Brands
14th Sep 20227:00 amRNSThe Apax Digital Fund II invests in Xeneta
19th Aug 20227:00 amRNS2022 Interim Dividend
19th Aug 20227:00 amRNS2022 Interim Report and Accounts
19th Aug 20227:00 amRNS2022 Interim Results Highlights
5th Aug 20227:00 amRNSApax Funds’ Valuations as at 30 June 2022
26th Jul 20227:00 amRNSFunds advised by Apax to acquire Pickles Auctions
29th Jun 20227:00 amRNSDirector/PDMR Shareholding
28th Jun 20227:00 amRNSProposed commitment to Apax XI
17th Jun 20227:00 amRNSDirector Declaration - Additional Directorship
10th Jun 20227:00 amRNSFunds Advised by Apax Sell Stake in MyCase
7th Jun 20227:00 amRNSFunds advised by Apax to acquire EcoOnline
13th May 20224:02 pmRNSDirector/PDMR Shareholding
12th May 20227:00 amRNSDirector/PDMR Shareholding
6th May 20227:00 amRNSResult of AGM
6th May 20227:00 amRNSIncrease to the Revolving Credit Facility
6th May 20227:00 amRNSQuarterly results for 31 March 2022
7th Apr 20227:00 amRNSProposed commitment to AMI Opportunities Fund II
22nd Mar 20227:00 amRNSApax Digital Funds invest in ClearBank
17th Mar 20223:59 pmRNSPurchase of Ordinary Shares under IM Agreement
8th Mar 20227:00 amRNSProposed commitment to Apax Global Impact Fund
2nd Mar 20227:00 amRNSKey Information Document
2nd Mar 20227:00 amRNS2021 Annual Dividend Declaration
2nd Mar 20227:00 amRNSNotice of AGM
2nd Mar 20227:00 amRNS2021 Annual Report and Accounts
2nd Mar 20227:00 amRNS2021 Final Results
14th Feb 20227:00 amRNSApax X invests in Alcumus and Ole Smoky
3rd Feb 20227:00 amRNSApax Funds’ Valuations as at 31 December 2021
31st Jan 20224:36 pmRNSPrice Monitoring Extension
23rd Dec 202110:30 amRNSDirector Declaration
17th Dec 20219:30 amRNSDirector Declaration
6th Dec 20217:00 amRNSFunds advised by Apax sell stakes in Unilabs
9th Nov 20217:00 amRNSInmarsat agrees combination with Viasat
4th Nov 20217:00 amRNSQuarterly results for 30 September 2021
2nd Nov 20217:00 amRNSFunds advised by Apax announce investment in Lever
1st Nov 20217:00 amRNSApax Funds to acquire HSG
6th Oct 20217:00 amRNSApax Funds to acquire Eating Recovery Center
16th Sep 20217:00 amRNSInitial Public Offering of Thoughtworks
8th Sep 20217:00 amRNSFunds advised by Apax to invest in T-Mobile
2nd Sep 20217:00 amRNSWizeline Acquired by CDPQ
1st Sep 20217:00 amRNSFunds advised by Apax to acquire SavATree
31st Aug 20215:40 pmRNSDirector/PDMR Shareholding
19th Aug 20217:00 amRNS2021 Interim Dividend
19th Aug 20217:00 amRNS2021 Interim Report and Accounts
19th Aug 20217:00 amRNS2021 Interim Results Highlights
5th Aug 20217:00 amRNSApax Funds’ Valuations as at 30 June 2021

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.